Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Wegovy drugmaker Novo Nordisk to make $70bn a year from weight-loss alone, as analysts await full SELECT trial data
11:09am, Thursday, 07'th Sep 2023
As researchers work to test whether Novo Nordisk (NYSE:NVO)'s fat-busting drug Wegovy can also be used as a treatment for dementia and alcohol addiction, some analysts are pointing to a potential "par
Is Novo Nordisk Stock a Buy Now?
10:07am, Thursday, 07'th Sep 2023
Novo Nordisk makes multiple weight loss and diabetes drugs, including Wegovy and Ozempic. Demand has been so strong the company has been using multiple contract manufacturers.
1 Weight-Loss Stock That's Been a Hotter Buy Than Eli Lilly and Novo Nordisk This Year
10:00am, Thursday, 07'th Sep 2023
Shares of WW International have been soaring this year as a result of some promising drugs. Even companies that aren't involved in making the drugs have piggybacked on the hype.
Novo Nordisk Is Already Working on Ozempic 2.0. Here's How to Profit
09:29am, Thursday, 07'th Sep 2023
Novo Nordisk is keen to replicate Ozempic's success. It just made two acquisitions that could lead to another big victory.
3 Nasdaq Stocks to Sell in September Before They Crash & Burn
08:41am, Thursday, 07'th Sep 2023
Due to what could be an unsustainable rally for equities, you may be looking for Nasdaq stocks to sell now. We've had an incredible run this year, but there are some additional indiciations that our l
CHART OF THE DAY: Ozempic maker Novo Nordisk overtakes LVMH to become the biggest company in Europe
11:44am, Wednesday, 06'th Sep 2023
Novo Nordisk is now the biggest company in Europe with a valuation of more than $425 billion. The biotech company has taken over luxury goods maker LVMH in market cap size.
How Novo Nordisk, Wegovy And Ozempic Are Changing The Weight Loss Game For Patients And Investors
03:47pm, Tuesday, 05'th Sep 2023
Novo Nordisk, the maker of Ozempic, for diabetes, and Wegovy, for obesity, is seeing revenue going off the scale. In fact, Wegovy saw a 344% gain in sales in just the first six months of 2023 in the U
Novo Nordisk (NVO) Launches Wegovy in UK Amid Supply Issues
03:02pm, Tuesday, 05'th Sep 2023
Novo Nordisk (NVO) announces the controlled and limited launch of Wegovy in the U.K. amid rising demand for weight loss treatment and supply constraints.
Novo Nordisk Becomes Europe's Most Valuable Company as Wegovy Launches in UK
10:45am, Tuesday, 05'th Sep 2023
American depositary receipts of Novo Nordisk (NVO) climbed 1.5% in early trading on Tuesday after launching its popular weight-loss drug, Wegovy, in the U.K.
Novo Nordisk Is Now Europe's Biggest Company, Driven by Weight-Loss Drug. How Eli Lilly Could Benefit.
05:06am, Tuesday, 05'th Sep 2023
The pharma company's Wegovy medication helps it overtake luxury goods maker LVMH, with a market value of around $420 billion.
Wegovy supply from Novo Nordisk has arrived in UK, Simple Online Pharmacy says
04:58am, Tuesday, 05'th Sep 2023
UK-based Simple Online Pharmacy has received stock of Novo Nordisk's weight-loss drug Wegovy, a company spokesperson said on Tuesday, one day after Novo launched the drug in Britain.
Novo Nordisk rolls out its weight loss drug Wegovy in the U.K.
04:02pm, Monday, 04'th Sep 2023
Novo Nordisk A/S (NYSE: NVO) is in focus on Monday after it launched its weight loss drug in another European market – the United Kingdom. Novo Nordisk is facing supply constraints But the pharmaceu
Pent-up private Wegovy demand prompts UK availability concerns
01:42pm, Monday, 04'th Sep 2023
People in Britain who can afford to pay out of their own pocket may get easier access to Novo Nordisk's weight-loss drug Wegovy than those seeking treatment in the country's state-run health service,
‘Miracle' weight-loss drug Wegovy will not be issued through major insurers
10:08am, Monday, 04'th Sep 2023
Several prominent UK-based insurers including Aviva, Axa, and WPA will not cover the costs of the newly launched weight-loss drug, Wegovy, under their private medical insurance policies. Since insur
Novo Nordisk's Wegovy weight loss drug launches in the UK
08:28am, Monday, 04'th Sep 2023
Novo Nordisk launched its Wegovy weight loss injection in the U.K. Monday, furthering the drug's rollout in Europe despite ongoing supply constraints.
